type 1 diabetes

FDA OKs Novo's Fiasp for diabetic children
FDA OKs Novo's Fiasp for diabetic children
Seeking Alpha
insulin
FDA
Novo Nordisk
Fiasp
pediatrics
diabetes
type 1 diabetes
Flag link:
Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
Reuters
Lexicon Pharmaceuticals
FDA
type 1 diabetes
Zynquista
Flag link:
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes
Zacks.com
Eli Lilly
Boehringer Ingelheim
FDA
Jardiance
type 1 diabetes
Flag link:
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Endpoints
Sanofi
clinical trials
type 1 diabetes
insulin
Toujeo
Flag link:
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
AstraZeneca
Farxiga
type 1 diabetes
heart failure
Flag link:
Artificial pancreas outperforms current tech in type 1 diabetes
Artificial pancreas outperforms current tech in type 1 diabetes
Pharmaforum
type 1 diabetes
devices
NIH
artificial pancreas
Control-IQ
Flag link:
Sanofi paying Lexicon $260M to exit diabetes alliance
Sanofi paying Lexicon $260M to exit diabetes alliance
BioPharma Dive
Sanofi
Lexicon Pharmaceuticals
diabetes
type 1 diabetes
Zynquista
Flag link:
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Stat
Vertex Pharmaceuticals
M&A
diabetes
type 1 diabetes
Semma Therapeutics
Flag link:
How one Boston startup rode the diabetes investment wave to raise $126M
How one Boston startup rode the diabetes investment wave to raise $126M
Bizjournals
Beta Bionics
type 1 diabetes
startups
devices
Flag link:
Sanofi ends partnership with Lexicon to develop add-on pill for diabetes
Sanofi ends partnership with Lexicon to develop add-on pill for diabetes
Yahoo/Reuters
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
type 2 diabetes
diabetes
insulin
Flag link:
AstraZeneca's Farxiga fails to get U.S. approval for Type-1 diabetes
AstraZeneca's Farxiga fails to get U.S. approval for Type-1 diabetes
Yahoo/Reuters
AstraZeneca
FDA
Farxiga
type 1 diabetes
Flag link:
Can A Drug That Delays The Onset Of Type 1 Diabetes Be A Success?
Can A Drug That Delays The Onset Of Type 1 Diabetes Be A Success?
Forbes
type 1 diabetes
Eli Lilly
teplizumab
Flag link:
Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show
Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show
BioSpace
Povention Bio
clinical trials
type 1 diabetes
ADA
immunotherapy
Flag link:
A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why
A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why
Stat
type 1 diabetes
checkpoint inhibitors
cancer
Flag link:
Harvard-born diabetes startup Semma reports advances in turning stem cells into insulin producers
Harvard-born diabetes startup Semma reports advances in turning stem cells into insulin producers
Fierce Biotech
Semma Therapeutics
type 1 diabetes
Flag link:
Sanofi, Lexicon get complete response letter for Zynquista
Sanofi, Lexicon get complete response letter for Zynquista
BioCentury
Sanofi
Zynquista
Lexicon Pharmaceuticals
type 1 diabetes
FDA
Flag link:
AI Used to ID Risk of Heart Disease in Diabetes Study
AI Used to ID Risk of Heart Disease in Diabetes Study
Medical Devices and Diagnostics Industry
type 1 diabetes
artificial intelligence
heart disease
diagnostics
Flag link:
AbbVie’s cancer drug Venclexta blocks diabetes in mice by targeting beta cell ‘senescence’
AbbVie’s cancer drug Venclexta blocks diabetes in mice by targeting beta cell ‘senescence’
Fierce Biotech
senescence
Venclexta
type 1 diabetes
AbbVie
Flag link:
JDRF Disappointed by UnitedHealthcare’s Preferred Medtronic Insulin Pump
JDRF Disappointed by UnitedHealthcare’s Preferred Medtronic Insulin Pump
Xtalks
type 1 diabetes
JDRF
Medtronic
devices
MiniMed 670G
UnitedHealthcare
Flag link:
AstraZeneca’s Forxiga recommended for marketing authorization in EU
AstraZeneca’s Forxiga recommended for marketing authorization in EU
Pharmaceutical Business Review
EMA
AstraZeneca
Forxiga
type 1 diabetes
CHMP
Flag link:

Pages